Susan Abushakra, Founder of Alzheon

About Susan Abushakra

Susan Abushakra, M.D., is the Chief Medical Officer at Alzheon, a clinical-stage biopharmaceutical company focused on developing new medicines for patients suffering from Alzheimer’s disease and other neurological and psychiatric disorders. Prior to joining Alzheon, Dr. Abushakra was the Chief Medical Officer at Transition Therapeutics and Elan/Perrigo. She has 15 years of neurological drug development expertise, including leadership roles at Elan Corporation, Allergan, Eisai, and Wyeth, working on drug candidates for neurological and psychiatric disorders, with a particular focus on Alzheimer's disease.

Susan Abushakra at a glance

• Company: Alzheon
• Total raised: $60M
• Latest round: Series D
• Location: Framingham, Massachusetts

More founders in Framingham, Massachusetts (28)

• Kevin Thompson — SolarWinds
• Lin Xiong — Ziroom
• Adam Persiani — Pharos Capital Partners
• Athena Countouriotis — Turning Point Therapeutics
• Wang Jianlin — Wanda Commercial Management Group
• Tom Hogan — Perficient
• Vishal Garg — Better.com
• Toshihiro Ueki — JOLED
• Yair Nechmad — Nayax
• Richard Walton — Archaea Energy
• Vladimir Lucic — Telekom Srbija
• He Xiaopeng — Xpeng Motors
• Gabriel Pereyra — Harvey
• Githesh Ramamurthy — CCC Information Services
• Mark Ritchie — Tallgrass Energy
• Jose Neves — Farfetch
• Changlin Liang — Dingdong Maicai
• George Sakellaris — Ameresco
• Ian Dundas — Enerplus
• Dan Bodner — Verint Systems
• Mike Mikan — Neuehealth
• Nathan Ough — VoltaGrid
• KS Choi — Samsung Austin Semiconductor
• Jon Medved — OurCrowd
• Tracy Meng — Checkout.com
• Aicha Evans — Zoox
• Greg Abovsky — Yandex
• Jeff Patton — OneOncology

Browse related founder lists (2)

• Founders in Framingham, Massachusetts
• Founders who raised $50M+

Full founder directory · Investor directory · Company funding database · Fundraising library